vorotintseyqah.blogspot.com
Gedeon Richter is an independent pharmaceutical company basedin Hungary. KV licensed women’e health products, including vaginal anti-infectives, to Gedeonj Richter, as well as in the U.S. for some Gedeom products. The new agreement gives Gedeomn Richter rights to make and distribute certain proprietary KV technologiese and products inits territories, includinbg the European Union. KV said it will receivd milestone payments and royalties for products developed under the but didn’t disclose the amounts. The agreementr also provides for future development ofadditional products. KV retaind the rights to the productz and technology inthe U.S.
Present in-licensex products, as well as Gedeon Richter'zs future proprietary development will be producedat Richter's facilities based on KV's technology according to a statement by Erik CEO of Gedeon Richter plc. Mo.-based KV has as of December, and halted all productioh andrecalled painkillers. KV said it entered into a consentt decree with the FDA that outlines a series of measuresa that will permit KV and its subsidiaries to resums manufacturingand distribution.
As part of the consen decree, KV has agreed not to market productzs it manufactures until it has satisfied certain requirementes designed to demonstrate compliancewith FDA'x current good manufacturing practicesw regulations. Brentwood, Mo.-based KV Pharmaceutical (NYSE: KVa, KVb) develops and market pharmaceutical products. David Van Vliet is KV’s
No comments:
Post a Comment